| Bhavik Dhyanesh Mehta, AA | |
|
1483 Devon Mill Way, Austell, GA 30168-5925 | |
| (404) 660-7646 | |
| Not Available |
| Full Name | Bhavik Dhyanesh Mehta |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 9 Years |
| Location | 1483 Devon Mill Way, Austell, Georgia |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013384205 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 2096 (* (Not Available)) | Primary |
| 367H00000X | Anesthesiologist Assistant | 7751 (Georgia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emory Decatur Hospital | Decatur, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emory Specialty Associates, Llc | 3476559782 | 430 |
News Archive
Investigators at Childrens Hospital Los Angeles have found that unlike adults, levels of serum beta-natriuretic peptide do not increase in pediatric trauma patients with serious head injuries.
A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study.
Compugen Ltd. announced today that administration of CGEN-15001 in an animal model of multiple sclerosis (MS) has been shown to completely abolish spontaneous relapses. In addition, administration of this novel molecule prior to disease onset demonstrated a pronounced delay of disease onset and a significant decrease in disease symptoms.
Respiratory and intestinal infections caused by RNA viruses stimulate infected cells to produce interferons, which can act alone or in combination to block virus replication.
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
› Verified 7 days ago
| Entity Name | Rockdale Anesthesia Services, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619028396 PECOS PAC ID: 4284536855 Enrollment ID: O20040123000436 |
News Archive
Investigators at Childrens Hospital Los Angeles have found that unlike adults, levels of serum beta-natriuretic peptide do not increase in pediatric trauma patients with serious head injuries.
A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study.
Compugen Ltd. announced today that administration of CGEN-15001 in an animal model of multiple sclerosis (MS) has been shown to completely abolish spontaneous relapses. In addition, administration of this novel molecule prior to disease onset demonstrated a pronounced delay of disease onset and a significant decrease in disease symptoms.
Respiratory and intestinal infections caused by RNA viruses stimulate infected cells to produce interferons, which can act alone or in combination to block virus replication.
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
› Verified 7 days ago
| Entity Name | Northlake Anesthesia Professionals,llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982637419 PECOS PAC ID: 2769471796 Enrollment ID: O20040506001031 |
News Archive
Investigators at Childrens Hospital Los Angeles have found that unlike adults, levels of serum beta-natriuretic peptide do not increase in pediatric trauma patients with serious head injuries.
A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study.
Compugen Ltd. announced today that administration of CGEN-15001 in an animal model of multiple sclerosis (MS) has been shown to completely abolish spontaneous relapses. In addition, administration of this novel molecule prior to disease onset demonstrated a pronounced delay of disease onset and a significant decrease in disease symptoms.
Respiratory and intestinal infections caused by RNA viruses stimulate infected cells to produce interferons, which can act alone or in combination to block virus replication.
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
› Verified 7 days ago
| Entity Name | Emory Specialty Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407864168 PECOS PAC ID: 3476559782 Enrollment ID: O20061010000447 |
News Archive
Investigators at Childrens Hospital Los Angeles have found that unlike adults, levels of serum beta-natriuretic peptide do not increase in pediatric trauma patients with serious head injuries.
A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study.
Compugen Ltd. announced today that administration of CGEN-15001 in an animal model of multiple sclerosis (MS) has been shown to completely abolish spontaneous relapses. In addition, administration of this novel molecule prior to disease onset demonstrated a pronounced delay of disease onset and a significant decrease in disease symptoms.
Respiratory and intestinal infections caused by RNA viruses stimulate infected cells to produce interferons, which can act alone or in combination to block virus replication.
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
› Verified 7 days ago
| Entity Name | Mak Anesthesia Holdings, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912452939 PECOS PAC ID: 4284917204 Enrollment ID: O20170216001563 |
News Archive
Investigators at Childrens Hospital Los Angeles have found that unlike adults, levels of serum beta-natriuretic peptide do not increase in pediatric trauma patients with serious head injuries.
A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study.
Compugen Ltd. announced today that administration of CGEN-15001 in an animal model of multiple sclerosis (MS) has been shown to completely abolish spontaneous relapses. In addition, administration of this novel molecule prior to disease onset demonstrated a pronounced delay of disease onset and a significant decrease in disease symptoms.
Respiratory and intestinal infections caused by RNA viruses stimulate infected cells to produce interferons, which can act alone or in combination to block virus replication.
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bhavik Dhyanesh Mehta, AA 1483 Devon Mill Way, Austell, GA 30168-5925 Ph: (404) 660-7646 | Bhavik Dhyanesh Mehta, AA 1483 Devon Mill Way, Austell, GA 30168-5925 Ph: (404) 660-7646 |
News Archive
Investigators at Childrens Hospital Los Angeles have found that unlike adults, levels of serum beta-natriuretic peptide do not increase in pediatric trauma patients with serious head injuries.
A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study.
Compugen Ltd. announced today that administration of CGEN-15001 in an animal model of multiple sclerosis (MS) has been shown to completely abolish spontaneous relapses. In addition, administration of this novel molecule prior to disease onset demonstrated a pronounced delay of disease onset and a significant decrease in disease symptoms.
Respiratory and intestinal infections caused by RNA viruses stimulate infected cells to produce interferons, which can act alone or in combination to block virus replication.
Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United States. Kiadis Pharma is currently enrolling patients in a multinational, pivotal clinical study at hospitals in Europe and Canada. With the approval of the IND, US hospitals will also participate in this study.
› Verified 7 days ago
Maggi Stuart Markwell, Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 3950 Austell Rd, Austell, GA 30106 Phone: 770-732-4000 | |
Reza H Mohammad, PAAA Anesthesiologist Assistant Medicare: May Accept Medicare Assignments Practice Location: 3950 Austell Road, Austell, GA 30106 Phone: 770-732-3649 Fax: 770-732-3648 | |
Ms. Whitney Ashlyn Wright, AA Anesthesiologist Assistant Medicare: May Accept Medicare Assignments Practice Location: 3950 Austell Rd, Austell, GA 30106 Phone: 770-732-5570 | |
Mbuomda Nasah Lima, PAAA Anesthesiologist Assistant Medicare: May Accept Medicare Assignments Practice Location: 3950 Austell Rd, Austell, GA 30106 Phone: 770-732-3649 Fax: 770-732-3648 | |
Elizabeth Jean Stubbs, AA-C Anesthesiologist Assistant Medicare: May Accept Medicare Assignments Practice Location: 3950 Austell Rd, Austell, GA 30106 Phone: 770-732-4000 | |
Melissa Wolff, PAAA Anesthesiologist Assistant Medicare: May Accept Medicare Assignments Practice Location: 3950 Austell Rd, Austell, GA 30106 Phone: 770-874-1911 |